iohexol has been researched along with Radiculopathy in 5 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Radiculopathy: Disease involving a spinal nerve root (see SPINAL NERVE ROOTS) which may result from compression related to INTERVERTEBRAL DISK DISPLACEMENT; SPINAL CORD INJURIES; SPINAL DISEASES; and other conditions. Clinical manifestations include radicular pain, weakness, and sensory loss referable to structures innervated by the involved nerve root.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JH | 2 |
| Yoon, DM | 1 |
| Kwon, TD | 1 |
| Yoon, KB | 1 |
| Jee, H | 1 |
| Kim, J | 1 |
| Park, KD | 1 |
| Lee, WY | 1 |
| Park, Y | 1 |
| Finn, KP | 1 |
| Case, JL | 1 |
| Gebarski, SS | 1 |
| Gabrielsen, TO | 1 |
| Knake, JE | 1 |
| Latack, JT | 1 |
| Hoff, JT | 1 |
| Vad, VB | 1 |
| Bhat, AL | 1 |
| Lutz, GE | 1 |
| Cammisa, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ultrasound-Guided Microendoscopic Versus Fluoroscopic-Guided Lumbar Transforaminal Epidural Steroid Injections: A Randomized Controlled Trial[NCT05729022] | 124 participants (Anticipated) | Interventional | 2023-12-01 | Not yet recruiting | |||
| Comparison of the Efficacy Between Transforaminal Steroid Epidural Injection and Epidural Neuroplasty for the Treatment of Herniated Lumbar Disc：A Single Center, Controlled Clinical Trial[NCT03101033] | 92 participants (Actual) | Interventional | 2015-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
ODI (Oswestry disability index) consists of 10 subscales, which evaluates pain intensity, and functional satus of personal care, lifting, walking, sitting, standing, sleeping, sex, social life, traveling. Each subscales range from 0 to 5, with the higher score indicating more severe functional damage. the ODI score ranges from 0 to 100. it equals the sum of all the subscales and divided by 50. If the patients answers 9 subscale questions, then the total sum should be divided by 45, and by this analogy. (NCT03101033)
Timeframe: at one-month post-treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Epidural Neuroplasty Group | 29.11 |
| Transforaminal Steroid Injection Group | 35.02 |
ODI (Oswestry disability index) consists of 10 subscales, which evaluates pain intensity, and functional satus of personal care, lifting, walking, sitting, standing, sleeping, sex, social life, traveling. Each subscales range from 0 to 5, with the higher score indicating more severe functional damage. the ODI score ranges from 0 to 100. it equals the sum of all the subscales and divided by 50. If the patients answers 9 subscale questions, then the total sum should be divided by 45, and by this analogy. (NCT03101033)
Timeframe: at six-month post-treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Epidural Neuroplasty Group | 30.52 |
| Transforaminal Steroid Injection Group | 46.39 |
ODI (Oswestry disability index) consists of 10 subscales, which evaluates pain intensity, and functional satus of personal care, lifting, walking, sitting, standing, sleeping, sex, social life, traveling. Each subscales range from 0 to 5, with the higher score indicating more severe functional damage. the ODI score ranges from 0 to 100. it equals the sum of all the subscales and divided by 50. If the patients answers 9 subscale questions, then the total sum should be divided by 45, and by this analogy. (NCT03101033)
Timeframe: at three-month post-treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Epidural Neuroplasty Group | 28.93 |
| Transforaminal Steroid Injection Group | 39.82 |
ODI (Oswestry disability index) consists of 10 subscales, which evaluates pain intensity, and functional satus of personal care, lifting, walking, sitting, standing, sleeping, sex, social life, traveling. Each subscales range from 0 to 5, with the higher score indicating more severe functional damage. the ODI score ranges from 0 to 100. it equals the sum of all the subscales and divided by 50. If the patients answers 9 subscale questions, then the total sum should be divided by 45, and by this analogy. (NCT03101033)
Timeframe: before treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Epidural Neuroplasty Group | 53.85 |
| Transforaminal Steroid Injection Group | 57.84 |
VAS (Visual analogue scale), with the highest score of 10, representing the most severe pain one could experience, and the lowest score of 0, representing no pain at all. The higher score means more severe pain. (NCT03101033)
Timeframe: at one-month post-treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Epidural Neuroplasty Group | 2.37 |
| Transforaminal Steroid Injection Group | 2.35 |
VAS (Visual analogue scale), with the highest score of 10, representing the most severe pain one could experience, and the lowest score of 0, representing no pain at all. The higher score means more severe pain. (NCT03101033)
Timeframe: at six-month post-treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Epidural Neuroplasty Group | 2.81 |
| Transforaminal Steroid Injection Group | 4.06 |
VAS (Visual analogue scale), with the highest score of 10, representing the most severe pain one could experience, and the lowest score of 0, representing no pain at all. The higher score means more severe pain. (NCT03101033)
Timeframe: at three-month post-treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Epidural Neuroplasty Group | 2.19 |
| Transforaminal Steroid Injection Group | 3.25 |
VAS (Visual analogue scale), with the highest score of 10, representing the most severe pain one could experience, and the lowest score of 0, representing no pain at all. The higher score means more severe pain. (NCT03101033)
Timeframe: before treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Epidural Neuroplasty Group | 5.63 |
| Transforaminal Steroid Injection Group | 5.92 |
1 review available for iohexol and Radiculopathy
| Article | Year |
|---|---|
Disk entry: a complication of transforaminal epidural injection--a case report.
Topics: Aged; Contrast Media; Fluoroscopy; Glucocorticoids; Humans; Injections, Epidural; Intervertebral Dis | 2005 |
3 trials available for iohexol and Radiculopathy
| Article | Year |
|---|---|
Ultrasound-guided selective nerve root block versus fluoroscopy-guided transforaminal block for the treatment of radicular pain in the lower cervical spine: a randomized, blinded, controlled study.
Topics: Analysis of Variance; Cervical Vertebrae; Chi-Square Distribution; Contrast Media; Female; Fluorosco | 2013 |
Iohexol versus metrizamide for lumbar myelography: preliminary report of double-blind trial.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Headache; Humans; Iodobenzoates; Iohexol; Lumb | 1984 |
Transforaminal epidural steroid injections in lumbosacral radiculopathy: a prospective randomized study.
Topics: Adult; Anesthetics, Local; Betamethasone; Contrast Media; Fluoroscopy; Follow-Up Studies; Hospitals, | 2002 |
1 other study available for iohexol and Radiculopathy
| Article | Year |
|---|---|
An evaluation of contrast medium spread on caudal epidurography with the needle positioned toward the affected side in patients with unilateral lumbosacral radiculopathy.
Topics: Contrast Media; Female; Humans; Injections, Epidural; Iohexol; Lumbosacral Plexus; Male; Middle Aged | 2012 |